Literature DB >> 17182672

Tissue-specific regulation of CD8+ T-lymphocyte immunodominance in respiratory syncytial virus infection.

Sujin Lee1, Scott A Miller, David W Wright, Michael T Rock, James E Crowe.   

Abstract

Cytotoxic T lymphocytes (CTLs) are critical for control of respiratory syncytial virus (RSV) infection in humans and mice. To investigate cellular immune responses to infection, it is important to identify major histocompatibility complex (MHC) class I-restricted CTL epitopes. In this study, we identified a new RSV-specific, H-2K(d)-restricted subdominant epitope in the M2 protein, M2(127-135) (amino acids 127 to 135). This finding allowed us to study the frequency of T lymphocytes responding to two H-2K(d)-presented epitopes in the same protein following RSV infection by enzyme-linked immunospot (ELISPOT) and intracellular cytokine assays for both lymphoid and nonlymphoid tissues. For the subdominant epitope, we identified an optimal nine-amino-acid peptide, VYNTVISYI, which contained an H-2K(d) consensus sequence with Y at position 2 and I at position 9. In addition, an MHC class I stabilization assay using TAP-2-deficient RMA-S cells transfected with K(d) or L(d) indicated that the epitope was presented by K(d). The ratios of T lymphocytes during the peak CTL response to RSV infection that were specific for M2(82-90) (dominant) to T lymphocytes specific for M2(127-135) (subdominant) were approximately 3:1 in the spleen and 10:1 in the lung. These ratios were observed consistently in primary or secondary infection by the ELISPOT assay and in secondary infection by MHC/peptide tetramer staining. The number of antigen-specific T lymphocytes dropped in the 6 weeks after infection; however, the proportions of T lymphocytes specific for the immunodominant and subdominant epitopes were maintained to a remarkable degree in a tissue-specific manner. These studies will facilitate investigation of the regulation of immunodominance of RSV-specific CTL epitopes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17182672      PMCID: PMC1865932          DOI: 10.1128/JVI.01910-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  46 in total

Review 1.  SYFPEITHI: database for MHC ligands and peptide motifs.

Authors:  H Rammensee; J Bachmann; N P Emmerich; O A Bachor; S Stevanović
Journal:  Immunogenetics       Date:  1999-11       Impact factor: 2.846

2.  A previously unrecognized H-2D(b)-restricted peptide prominent in the primary influenza A virus-specific CD8(+) T-cell response is much less apparent following secondary challenge.

Authors:  G T Belz; W Xie; J D Altman; P C Doherty
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

3.  Respiratory syncytial virus vaccine development.

Authors:  J E Crowe
Journal:  Vaccine       Date:  2001-10-15       Impact factor: 3.641

4.  Measuring the diaspora for virus-specific CD8+ T cells.

Authors:  D R Marshall; S J Turner; G T Belz; S Wingo; S Andreansky; M Y Sangster; J M Riberdy; T Liu; M Tan; P C Doherty
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-08       Impact factor: 11.205

5.  Virus-specific CTL responses induced by an H-2K(d)-restricted, motif-negative 15-mer peptide from the fusion protein of respiratory syncytial virus.

Authors:  Shisong Jiang; Nicola J Borthwick; Paul Morrison; George F Gao; Michael W Steward
Journal:  J Gen Virol       Date:  2002-02       Impact factor: 3.891

6.  Intestinal and splenic T cell responses to enteric Listeria monocytogenes infection: distinct repertoires of responding CD8 T lymphocytes.

Authors:  J W Huleatt; I Pilip; K Kerksiek; E G Pamer
Journal:  J Immunol       Date:  2001-03-15       Impact factor: 5.422

7.  Visualization and characterization of respiratory syncytial virus F-specific CD8(+) T cells during experimental virus infection.

Authors:  J Chang; A Srikiatkhachorn; T J Braciale
Journal:  J Immunol       Date:  2001-10-15       Impact factor: 5.422

8.  Diversity of epitope and cytokine profiles for primary and secondary influenza a virus-specific CD8+ T cell responses.

Authors:  G T Belz; W Xie; P C Doherty
Journal:  J Immunol       Date:  2001-04-01       Impact factor: 5.422

9.  The attachment (G) glycoprotein of respiratory syncytial virus contains a single immunodominant epitope that elicits both Th1 and Th2 CD4+ T cell responses.

Authors:  S M Varga; E L Wissinger; T J Braciale
Journal:  J Immunol       Date:  2000-12-01       Impact factor: 5.422

10.  Noncompetitive expansion of cytotoxic T lymphocytes specific for different antigens during bacterial infection.

Authors:  S Vijh; I M Pilip; E G Pamer
Journal:  Infect Immun       Date:  1999-03       Impact factor: 3.441

View more
  17 in total

1.  Novel HLA-A2-restricted human metapneumovirus epitopes reduce viral titers in mice and are recognized by human T cells.

Authors:  Andrew K Hastings; Pavlo Gilchuk; Sebastian Joyce; John V Williams
Journal:  Vaccine       Date:  2016-04-19       Impact factor: 3.641

2.  Dendritic Cells Targeting Lactobacillus plantarum Strain NC8 with a Surface-Displayed Single-Chain Variable Fragment of CD11c Induce an Antigen-Specific Protective Cellular Immune Response.

Authors:  Jing Liu; Guilian Yang; Haibin Huang; Chunwei Shi; Xing Gao; Wentao Yang; Zan Zhang; Yang Liu; Ke Xu; Jianzhong Wang; Yuanhuan Kang; Yanlong Jiang; Chunfeng Wang
Journal:  Infect Immun       Date:  2020-01-22       Impact factor: 3.441

3.  Live attenuated influenza vaccine viral vector induces functional cytotoxic T-cell immune response against foreign CD8+ T-cell epitopes inserted into NA and NS1 genes using the 2A self-cleavage site.

Authors:  Tatiana Kotomina; Daniil Korenkov; Victoria Matyushenko; Polina Prokopenko; Larisa Rudenko; Irina Isakova-Sivak
Journal:  Hum Vaccin Immunother       Date:  2018-08-29       Impact factor: 3.452

4.  Responses against a subdominant CD8+ T cell epitope protect against immunopathology caused by a dominant epitope.

Authors:  Tracy J Ruckwardt; Cindy Luongo; Allison M W Malloy; Jie Liu; Man Chen; Peter L Collins; Barney S Graham
Journal:  J Immunol       Date:  2010-09-10       Impact factor: 5.422

5.  Vaccine-elicited CD8+ T cells protect against respiratory syncytial virus strain A2-line19F-induced pathogenesis in BALB/c mice.

Authors:  Sujin Lee; Kate L Stokes; Michael G Currier; Kaori Sakamoto; Nicholas W Lukacs; Esteban Celis; Martin L Moore
Journal:  J Virol       Date:  2012-09-26       Impact factor: 5.103

6.  Enhancement of the CD8+ T cell response to a subdominant epitope of respiratory syncytial virus by deletion of an immunodominant epitope.

Authors:  Hoyin Mok; Sujin Lee; David W Wright; James E Crowe
Journal:  Vaccine       Date:  2008-07-26       Impact factor: 3.641

7.  Characterization of respiratory syncytial virus M- and M2-specific CD4 T cells in a murine model.

Authors:  Jie Liu; Tracy J Ruckwardt; Man Chen; Teresa R Johnson; Barney S Graham
Journal:  J Virol       Date:  2009-03-04       Impact factor: 5.103

Review 8.  Pulmonary immunity and immunopathology: lessons from respiratory syncytial virus.

Authors:  Matthew R Olson; Steven M Varga
Journal:  Expert Rev Vaccines       Date:  2008-10       Impact factor: 5.217

9.  The number of respiratory syncytial virus (RSV)-specific memory CD8 T cells in the lung is critical for their ability to inhibit RSV vaccine-enhanced pulmonary eosinophilia.

Authors:  Matthew R Olson; Stacey M Hartwig; Steven M Varga
Journal:  J Immunol       Date:  2008-12-01       Impact factor: 5.422

10.  Regulatory T cells promote early influx of CD8+ T cells in the lungs of respiratory syncytial virus-infected mice and diminish immunodominance disparities.

Authors:  Tracy J Ruckwardt; Kathryn L Bonaparte; Martha C Nason; Barney S Graham
Journal:  J Virol       Date:  2009-01-19       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.